Table 1. Differential diagnoses in myelodysplastic syndrome and appropriate diagnostic tests for identifying myelodysplastic syndromes.
| Differential diagnosis | Diagnostic tests |
|---|---|
| Aplastic anemia, pure red cell aplasia (PRCA) | Histology, cytology, parvovirus B19 |
| Toxic bone marrow injury (alcohol, lead, NSAR, etc.) | History, lab tests |
| Reactive bone marrow changes (sepsis, HIV, chronic infections, Tbc, autoimmune diseases etc.), copper deficiency | Cytology, history, lab tests |
| Monocytosis of other etiology | History, lab tests, molecular genetic testing |
| Paroxysmal nocturnal hemoglobinuria (PNH) | Immunophenotyping |
| Immune thrombocytopenia | History, course |
| Megaloblastic anemia | Vitamin B12/folic acid concentration |
| Hypersplenic syndromes | History/clinical features (splenomegaly) |
| Acute leukemia (especially erythroleukemia, FAB-M6) | Cytology, genetic and molecular genetic testing |
| Myeloproliferative diseases (especially aCML, PMF) | Histology, cytogenetic and molecular genetic testing |
| Hairy cell leukemia, LGL | Cytology, immunophenotyping, molecular genetic testing (braf, stat3), T-cell receptor |
| Congenital dyserythropoietic anemia (rare) | Moleculargenetic (sec23b und cdan-1) |
NSAR, nonsteroidal antirheumatics; Tbc, tuberculosis; aCML, atypical chronic myeloid leukemia; PMF, primary myelofibrosis; LGL, large granular lymphoma